Anirban Maitra, Professor of Pathology and Medicine at NYU Langone Health, shared a post on X:
“Bold headline! Cannot wait to start testing this premise in patients.
But if we are taking the aspirin analogy, What is considered ‘well tolerated’ in a patient with cancer is vastly different from a cancer interception setting.
Getting there though….And likely pretty soon!
From The Cancer Letter
KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill.”
More posts featuring Frank McCormick.
